Figure 3
Figure 3. SNP 6.0 array–based lesion cutoffs and IgVH status or ZAP70 status and OS in CLL (bivariate analysis; Kaplan-Meier plots). Previously untreated patient group was analyzed from trial enrollment (A-C) IgVH status and various SNP 6.0 array–based lesion cutoffs and (D-F) ZAP70 status and various SNP 6.0 array–based lesion cutoffs.

SNP 6.0 array–based lesion cutoffs and IgVH status or ZAP70 status and OS in CLL (bivariate analysis; Kaplan-Meier plots). Previously untreated patient group was analyzed from trial enrollment (A-C) IgVH status and various SNP 6.0 array–based lesion cutoffs and (D-F) ZAP70 status and various SNP 6.0 array–based lesion cutoffs.

Close Modal

or Create an Account

Close Modal
Close Modal